Homburger advised Novo Nordisk on its USD 11 billion acquisition of three manufacturing sites from Novo Holdings. The completion follows the finalization of Novo Holdings’ acquisition of Catalent. The three acquired sites specialized in the sterile
Homburger advised Novo Nordisk on its USD 11 billion acquisition of three manufacturing sites from Novo Holdings. The completion follows the finalization of Novo Holdings’ acquisition of Catalent. The three acquired sites specialized in the sterile